Background Depression is more common among rheumatoid arthritis (RA) patients than in the general population. Depressive symptoms (DS) may increase work disability (WD), and also reduce treatment adherence in RA. Objectives Our aim was to investigate the impact of DS on cumulative work disability...
Cancer incidence and mortality rates keep increasing yearly [1]. The complexity of curing cancer partially arises from the inconspicuous nature of early symptoms that usually results in delayed diagnoses and treatments [2,3]. Previous studies have shown the pivotal role of regular breast cancer scree...
Patients with a longer duration of symptoms at RA diagnosis are more likely to have early erosions or arthritis-related JSN. There was also an association between RF and early erosions, which is compatible with previous studies. High levels of laboratory markers of inflammation were associated ...
Background Rheumatoid Arthritis (RA) is a chronic inflammatory systemic disease that mainly affects joints and with symptoms such as stiffness, pain, and increased fatigue. RA also appears to be an independent risk factor for accelerated atherosclerosis with an increased risk of cardiovascular diseases...
rheumatoid arthritis, lupus, inflammatory bowel disease. So what happens in any autoimmune disease is the immune system, which is the system that normally keeps us healthy, kills the bacteria and viruses, it goes awry. And it identifies the beta cells of the pancreas, tho...
arthritis sub-types. In avery earlyarthritis cohort of 634 patients with symptoms ≤ 16 weeks duration, the ankle joint (18.9%) was the second most frequently involved joint after the knee (47.3%) in those with monoarthritis. In oligoarthritis (2-4 joints affected) the distribution of joint...
To evaluate the efficacy and safety of upadacitinib monotherapy versus methotrexate (MTX) monotherapy over 5 years among MTX-naïve patients with moderately to severely active rheumatoid arthritis (RA) in the long-term extension (LTE) of the phase 3 SELECT-EARLY trial. Methods Patients were ran...
SAN FRANCISCO — For patients with rheumatoid arthritis, baricitinib monotherapy is more effective than methotrexate monotherapy and more effective than the combination of methotrexate and baricitinib, according to a phase 3 trial. Baricitinib produced larger and more rapid improvements and higher rates of...
To evaluate the efficacy and safety of upadacitinib monotherapy versus methotrexate (MTX) monotherapy over 5 years among MTX-naïve patients with moderately to severely active rheumatoid arthritis (RA) in the long-term extension (LTE) of the phase 3 SE